BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Scott Weiner is participating on a panel at the Greater Philadelphia Alliance for Capital and Technologies IMPACT 2010 Conference in Philadelphia, PA
News | 11. 09. 2010
